To buy shares listed in Australia such as Imugene , you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for beginner
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $0.039 - $0.15 |
|---|---|
| 50-day moving average | $0.1086 |
| 200-day moving average | $0.0888 |
| Target price | $0.34 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.01 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.085
| 1 week (2024-04-16) | 2.41% |
|---|---|
| 1 month (2024-03-22) | -19.05% |
| 3 months (2024-01-24) | -15.00% |
| 6 months (2023-10-24) | 93.18% |
| 1 year (2023-04-24) | -34.62% |
|---|---|
| 2 years (2022-04-22) | -62.22% |
| 3 years (2021-04-23) | -55.26% |
| 5 years (2019-04-24) | 372.22% |
| Revenue TTM | $15 million |
|---|---|
| Gross profit TTM | $11.8 million |
| Return on assets TTM | -26.15% |
| Return on equity TTM | -44.37% |
| Profit margin | 0% |
| Book value | 0.027 |
| Market capitalisation | $613.7 million |
TTM: trailing 12 months
We're not expecting Imugene to pay a dividend over the next 12 months.
Imugene 's shares were split on a 1:7.5 basis on 11 November 2002. So if you had owned 7.5 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Imugene shares – just the quantity. However, indirectly, the new 650% higher share price could have impacted the market appetite for Imugene shares which in turn could have impacted Imugene 's share price.
Over the last 12 months, Imugene 's shares have ranged in value from as little as $0.039 up to $0.15. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Imugene 's is 3.208. This would suggest that Imugene 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in phase 2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling and is in phase I trial; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a collaboration with Arovella Therapeutics Ltd to test the integration of Arovella's CAR19- iNKT cell therapy with the onCARlytics platform, as well as a research collaboration with RenovoRx, Inc. to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia.
AMP Ltd Preferred
AUD104.90
ANZ Group Holdings Ltd. Pfd.
AUD101.63
ANZ Group Holdings Ltd. Pfd.
AUD103.09
Macquarie Bank Ltd Pref
AUD106.32
Macquarie Group Ltd Pref C
AUD102.93
Macquarie Group Ltd Pref
AUD105.63
Macquarie Group Preferred
AUD102.66
Macquarie Group Limited
AUD105.95
Suncorp Group Ltd Pref
AUD100.61
Westpac Banking Corp Pref
AUD102.80
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Blinklab shares.
Everything we know about the Maverick Minerals IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a flat $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?